Structured Summary
Abstract
Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
4 entry terms
- Leukocidin Proteins
- Proteins, Leukocidin
- Leucocidin
- Leukocidin
MeSH Record
Aspects Covered
27 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
Indexing Annotation
/antag permitted but consider also ANTITOXINS
MeSH Record
History Note
78; was LEUKOCIDIN 1965-77
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Leukocidins. Medical Subject Headings (MeSH). 2026. Unique ID D007956. http://id.nlm.nih.gov/mesh/2026/D007956
- Leukocidins. In: Wikipedia. https://en.wikipedia.org/wiki/Leukocidin
- Leukocidins. In: Wikidata. https://www.wikidata.org/wiki/Q16889545